Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Cadmium as a placental endocrine disruptor in humans (CROSBI ID 590150)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Piasek, Martina ; Jurasović, Jasna ; Mikolić, Anja ; Stasenko, Sandra ; Kušec, Vesna ; Henson, Michael C. Cadmium as a placental endocrine disruptor in humans // Toxicology letters. 2012. str. S37-S38

Podaci o odgovornosti

Piasek, Martina ; Jurasović, Jasna ; Mikolić, Anja ; Stasenko, Sandra ; Kušec, Vesna ; Henson, Michael C.

engleski

Cadmium as a placental endocrine disruptor in humans

Tobacco smoke may be considered a mixture of endocrine-disrupting chemicals. It consists of numerous elements and compounds including 30 metal ions with cadmium concentration being the highest. There is emerging evidence that cadmium has potential to act as an endocrine disruptor of gonads and reproductive function in mammals, including humans. It can alter ovarian and placental steroidogenesis, ovarian cyclicity, and pregnancy maintenance. The role of inheritable developmental toxicity related to endocrine disruption is poorly understood. Trophoblast-produced leptin may regulate fetal organogenesis and development. We conducted complementary studies on cadmium-related hormone disruption in human and rodent placenta: ex vivo analyses of progesterone and estradiol in placental tissue of healthy cigarette smokers post partum whose placental cadmium concentrations were twice as high as respective levels in nonsmokers ; in vivo assessment of direct cadmium effects on progesterone and leptin production in human trophoblast cells co-cultured with CdCl2 ; assessment of placental steroidogenesis in rats after parenteral and oral cadmium exposure during gestation. We found that increased cadmium concentrations were accompanied by decreased progesterone production in both human and rodent placenta. Direct effects of cadmium on placental hormone production included specific components of the steroidogenic pathway, that is, effects on the low-density lipoprotein-cholesterol receptor and P450 side chain cleavage enzyme, as well as a dose-response decline of leptin mRNA. To conclude, cadmium has the potential to disrupt steroid and leptin production in human placenta. The sites of cadmium effects on specific components of the placental hormone biosynthetic pathway are multifaceted.

cadmium; estradiol; leptin; placenta; progesterone; tobacco smoke

Presented on 19th June 2012, Oral session OS2 "Endocrine-disruptors"

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

S37-S38.

2012.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Toxicology letters

Elsevier

0378-4274

Podaci o skupu

EUROTOX 2012, 48th Congress of the European Societies of Toxicology "Safety Science Serving Society"

predavanje

17.06.2012-20.06.2012

Stockholm, Švedska

Povezanost rada

Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita

Indeksiranost